TY - JOUR
T1 - Hyperinsulinemic hypoglycemia subtype glucokinase V91L mutant induces necrosis in β-cells via ATP depletion
AU - Lu, Brian
AU - Tonne, Jason M.
AU - Munoz-Gomez, Miguel
AU - Ikeda, Yasuhiro
N1 - Funding Information:
This work was supported by the Vann Family Fund in Diabetes Research , Kieckhefers Foundation , Paul A. and Ruth M. Schilling Medical Research Endowment Fund , and Mayo Clinic Center for Regenerative Medicine (to YI), and Mayo Clinic Graduate School of Biomedical Sciences (to BL), and Initiative for Maximizing Student Development (IMSD, to BL).
Publisher Copyright:
© 2018 The Authors
PY - 2019/3
Y1 - 2019/3
N2 - Hyperinsulinemic hypoglycemia subtype glucokinase (GCK-HH) is caused by an activating mutation in glucokinase (GCK) and has been shown to increase β-cell death. However, the mechanism of β-cell death in GCK-HH remains poorly understood. Here, we expressed the GCK-HH V91L GCK mutant in INS-1 832/13 cells to determine the effect of the mutation on β-cell viability and the mechanisms of β-cell death. We showed that expression of the V91L GCK mutant in INS-1 832/13 cells resulted in a rapid glucose concentration-dependent loss of cell viability. At 11 mM D-glucose, INS-1 832/13 cells expressing V91L GCK showed increased cell permeability without significant increases in Annexin V staining or caspase 3/7 activation, indicating that these cells are primarily undergoing cell death via necrosis. Over-expression of SV40 large T antigen, which inhibits the p53 pathway, did not affect the V91L GCK-induced cell death. We also found that non-phosphorylatable L-glucose did not induce rapid cell death. Of note, glucose phosphorylation coincided with a 90% loss of intracellular ATP content. Thus, our data suggest that the GCK V91L mutant induces rapid necrosis in INS-1 cells through accelerated glucose phosphorylation, ATP depletion, and increased cell permeability.
AB - Hyperinsulinemic hypoglycemia subtype glucokinase (GCK-HH) is caused by an activating mutation in glucokinase (GCK) and has been shown to increase β-cell death. However, the mechanism of β-cell death in GCK-HH remains poorly understood. Here, we expressed the GCK-HH V91L GCK mutant in INS-1 832/13 cells to determine the effect of the mutation on β-cell viability and the mechanisms of β-cell death. We showed that expression of the V91L GCK mutant in INS-1 832/13 cells resulted in a rapid glucose concentration-dependent loss of cell viability. At 11 mM D-glucose, INS-1 832/13 cells expressing V91L GCK showed increased cell permeability without significant increases in Annexin V staining or caspase 3/7 activation, indicating that these cells are primarily undergoing cell death via necrosis. Over-expression of SV40 large T antigen, which inhibits the p53 pathway, did not affect the V91L GCK-induced cell death. We also found that non-phosphorylatable L-glucose did not induce rapid cell death. Of note, glucose phosphorylation coincided with a 90% loss of intracellular ATP content. Thus, our data suggest that the GCK V91L mutant induces rapid necrosis in INS-1 cells through accelerated glucose phosphorylation, ATP depletion, and increased cell permeability.
KW - Beta-cell death
KW - Glucokinase
KW - Hyperinsulinemic hypoglycemia
KW - Hyperinsulinemic hypoglycemia subtype glucokinase
KW - Necrosis
UR - http://www.scopus.com/inward/record.url?scp=85058647578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058647578&partnerID=8YFLogxK
U2 - 10.1016/j.bbrep.2018.12.002
DO - 10.1016/j.bbrep.2018.12.002
M3 - Article
AN - SCOPUS:85058647578
SN - 2405-5808
VL - 17
SP - 108
EP - 113
JO - Biochemistry and Biophysics Reports
JF - Biochemistry and Biophysics Reports
ER -